Scott Henry
Stock Analyst at Alliance Global Partners
(1.64)
# 3,088
Out of 4,829 analysts
61
Total ratings
37.74%
Success rate
-5.11%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.13 | +165.49% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.26 | +197.62% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $3.00 | +100.00% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.24 | +208.64% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.61 | +350.82% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $6.88 | +23.55% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.06 | +277.36% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.65 | +809.09% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.82 | +1,363.95% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.22 | +20.58% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $14.84 | -12.40% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $27.55 | -12.89% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $104.48 | -13.86% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $23.37 | -33.68% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $80.26 | -27.73% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $52.41 | -31.31% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.15 | +856.52% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.51 | +33.04% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.35 | +245,102.56% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.84 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $3.20 | +118.75% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.83 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.56 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.09 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.13
Upside: +165.49%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.26
Upside: +197.62%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $3.00
Upside: +100.00%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.24
Upside: +208.64%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.61
Upside: +350.82%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $6.88
Upside: +23.55%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.06
Upside: +277.36%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.65
Upside: +809.09%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.82
Upside: +1,363.95%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.22
Upside: +20.58%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $14.84
Upside: -12.40%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $27.55
Upside: -12.89%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $104.48
Upside: -13.86%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $23.37
Upside: -33.68%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $80.26
Upside: -27.73%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $52.41
Upside: -31.31%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.15
Upside: +856.52%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.51
Upside: +33.04%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.35
Upside: +245,102.56%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.84
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $3.20
Upside: +118.75%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $18.83
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $5.09
Upside: -